1. Tadesse M, Gulliksen B, Strom MB, et al. Screening For Antibacterial And Antifungal Activities In Marine Benthic Invertebrates From Northern Norway. J Invertebr Pathol 2008; 99(3): 286-93. [
DOI:10.1016/j.jip.2008.06.009]
2. Lee YK, Lee JH, Lee HK. Microbial Symbiosis In Marine Sponges. J Microbiol 2000; 39(4): 254-64.
3. Belarbi EH, Contreras Gomez A, Chisti Y, et al. Producing Drugs From Marine Sponges. Biotechnol Adv 2003; 21(7): 585-98. [
DOI:10.1016/S0734-9750(03)00100-9]
4. Thakur NL, Müller WEG. Biotechnological Potential Of Marine Sponges. Curr Sci 2004; 86(11): 1506-12.
5. Archibald LK, Manning ML, Bell LM, et al. Patient Density, Nurse-To-Patient Ratio And Nosocomial Infection Risk In A Pediatric Cardiac Intensive Care Unit. Pediatr Infect Dis J 1997; 16(11): 1045-8. [
DOI:10.1097/00006454-199711000-00008]
6. NNIS System, Gerberding J, Gaynes R, et al. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary From January 1990-May 1999. A Report From The NNIS System. Am J Infect Control 1999; 27(6): 520-32. [
DOI:10.1016/S0196-6553(99)70031-3]
7. Laport MS, Santos OC, Muricy G. Marine Sponges: Potential Sources Of New Antimicrobial Drugs. Curr Pharm Biotechnol 2009; 10(1): 86-105. [
DOI:10.2174/138920109787048625]
8. Nyan LK, Abas F, Maulidiani M, et al. Chemical Constituents And Biological Activities Of South East Asia Marine Sponges: A Review. Pertanika J Sci Technol 2019; 27(2): 953-83.
9. Mayer AMS, Guerrero AJ, Rodríguez AD, et al. Marine Pharmacology In 2014-2015: Marine Compounds With Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, And Anthelmintic Activities; Affecting The Immune And Nervous Systems, And Other Miscellaneous Mechanisms Of Action. Mar Drugs 2019; 18(1): 5. [
DOI:10.3390/md18010005]
10. Mohebbi GH, Nabipour I, Vazirizadeh A. The Sea, the Future Pharmacy. Iran South Med J 2014; 17(4): 748-88. (Persian)
11. Safaeian S, Hosseini H, Abbas Pour Asadolah A, et al. Antimicrobial Activity Of Marine Sponge Extracts Of Offshore Zone From Nay Band Bay, Iran. J Mycol Med 2009; 19(1): 11-6. [
DOI:10.1016/j.mycmed.2008.11.003]
12. Nazemi M, Moradi Y, Rezvani Gilkolai F, et al. Antimicrobial Activities Of Semi PolarNonpolar And Polar Secondary Metabolites Of Sponge Dysidea Pallescens From Hengam Island, Persian Gulf. Iran J Fish Sci 2017; 16(1): 200-9.
13. Seradj H, Moein M, Eskandari M, et al. Antioxidant Activity Of Six Marine Sponges Collected From The Persian Gulf. Iran J Pharm Sci 2012; 8(4): 249-55.
14. Zaini F, Mahbod MSA, Emami M. Comprehensive Medical Mycology. 2 nd ed. Tehran: Tehran University Medical Sciences Press, 2004. (Persian)
15. Roll DM, Ireland CM, Lu HSM, et al. An Unusual Antimicrobial Pigment From The Marine Sponge Fascaplysinopsis Sp. J Org Chem 1988; 53(14): 3276-8. [
DOI:10.1021/jo00249a025]
16. Bibi F, Faheem M, Azhar E, et al. Bacteria From Marine Sponges: A Source Of New Drugs. Curr Drug Metab 2017; 18(11): 11-5. [
DOI:10.2174/1389200217666161013090610]
17. Campos PE, Pichon E, Moriou C, et al. New Antimalarial And Antimicrobial Tryptamine Derivatives From The Marine Sponge Fascaplysinopsis Reticulata. Mar Drugs 2019; 17(3): 167. [
DOI:10.3390/md17030167]
18. Qin GF, Tang XL, De Voogd NJ, et al. Cytotoxic Components From The Xisha Sponge Fascaplysinopsis Reticulata. Nat Prod Res 2020; 34(6): 790-6. [
DOI:10.1080/14786419.2018.1502765]
19. Wang Q, Tang X, Luo X, et al. (+)- And (−)- Spiroreticulatine, A Pair Of Unusual Spiro Bisheterocyclic Quinoline-Imidazole Alkaloids From The South China Sea Sponge Fascaplysinopsis Reticulata. Org Lett 2015; 17(14): 3458-61. [
DOI:10.1021/acs.orglett.5b01503]
20. Nazemi M, Motallebi Moghanjoghi AA, Jamili S, et al. Comparison Of Antibacterial Activities Of Ircinia Mutans Extracts In Two Different Seasons From Kish Island, Persian Gulf, Iran. Iran J Fish Sci 2014; 13(4): 823-33.
21. Govinden-Soulange J, Marie D, Kauroo S, et al. Antibacterial Properties Of Marine Sponges From Mauritius Waters. Trop J Pharm Res 2014; 13(2): 249-54. [
DOI:10.4314/tjpr.v13i2.13]